Absorbent, gelling, fibrous dressing
- UID
- IMP/MD/2020/000566_14b2ae60f3bd83125f9f88a39bf8ce47_a9c7114b417e400ef0fadd60500fb5b6
- Device class
- Class B
- Brand name
- IV3000
- License holder
- Smith & Nephew Healthcare Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- DURAFIBER is indicated as an absorbent, gelling dressing for the management of chronic and acute, full thickness, partial thickness, or shallow granulating exuding wounds. For example: leg ulcers; pressure ulcers; diabetic ulcers; surgical wounds; wounds left to heal by secondary intent; donor sites; tunneling and fistulae wounds; partial thickness burns; traumatic wounds; and wounds that are prone to bleeding such as wounds that have been surgically or mechanically debrided. DURAFIBER is designed to be left in place for up to 7 days.
Absorbent, gelling, fibrous dressing is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000566_14b2ae60f3bd83125f9f88a39bf8ce47_a9c7114b417e400ef0fadd60500fb5b6. This device is marketed under the brand name IV3000. The license holder is Smith & Nephew Healthcare Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.